KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,395 | -64.0% | 22,683 | -52.0% | 0.00% | – |
| Q2 2023 | $84,518 | -87.0% | 47,217 | -71.8% | 0.00% | – |
| Q1 2023 | $652,123 | +157038.1% | 167,641 | +137310.7% | 0.00% | – |
| Q4 2022 | $415 | -98.6% | 122 | -97.8% | 0.00% | – |
| Q3 2022 | $30,000 | -3.2% | 5,648 | -17.6% | 0.00% | – |
| Q2 2022 | $31,000 | -89.7% | 6,851 | -83.2% | 0.00% | – |
| Q1 2022 | $302,000 | -28.8% | 40,876 | -37.9% | 0.00% | – |
| Q4 2021 | $424,000 | +186.5% | 65,868 | +159.4% | 0.00% | – |
| Q3 2021 | $148,000 | -53.2% | 25,390 | -17.2% | 0.00% | – |
| Q2 2021 | $316,000 | -71.3% | 30,656 | -70.7% | 0.00% | – |
| Q1 2021 | $1,100,000 | -55.9% | 104,578 | -35.1% | 0.00% | -100.0% |
| Q4 2020 | $2,493,000 | -4.6% | 161,023 | -10.0% | 0.00% | 0.0% |
| Q3 2020 | $2,614,000 | -23.7% | 179,008 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $3,425,000 | +181.0% | 180,794 | +185.1% | 0.00% | – |
| Q1 2020 | $1,219,000 | +3.6% | 63,409 | +3.2% | 0.00% | – |
| Q4 2019 | $1,177,000 | +106.1% | 61,425 | +3.5% | 0.00% | – |
| Q3 2019 | $571,000 | +58.2% | 59,320 | -1.8% | 0.00% | – |
| Q2 2019 | $361,000 | +11.1% | 60,384 | +8.6% | 0.00% | – |
| Q1 2019 | $325,000 | -23.7% | 55,623 | +22.2% | 0.00% | – |
| Q4 2018 | $426,000 | -40.8% | 45,519 | +7.7% | 0.00% | – |
| Q3 2018 | $720,000 | +14.5% | 42,274 | +14.1% | 0.00% | – |
| Q2 2018 | $629,000 | +30.2% | 37,035 | +2.8% | 0.00% | – |
| Q1 2018 | $483,000 | +62.1% | 36,036 | +16.3% | 0.00% | – |
| Q4 2017 | $298,000 | +4.6% | 30,974 | +18.8% | 0.00% | – |
| Q3 2017 | $285,000 | +33.8% | 26,072 | +10.7% | 0.00% | – |
| Q2 2017 | $213,000 | -62.0% | 23,552 | -46.0% | 0.00% | – |
| Q1 2017 | $560,000 | +193.2% | 43,606 | +114.6% | 0.00% | – |
| Q4 2016 | $191,000 | +48.1% | 20,322 | +52.9% | 0.00% | – |
| Q3 2016 | $129,000 | +41.8% | 13,295 | -2.9% | 0.00% | – |
| Q2 2016 | $91,000 | -32.1% | 13,695 | -9.7% | 0.00% | – |
| Q1 2016 | $134,000 | -92.5% | 15,172 | -88.8% | 0.00% | -100.0% |
| Q4 2015 | $1,787,000 | +1453.9% | 134,886 | +1133.5% | 0.00% | – |
| Q3 2015 | $115,000 | -59.8% | 10,935 | +4.1% | 0.00% | – |
| Q2 2015 | $286,000 | +17.2% | 10,503 | +32.7% | 0.00% | – |
| Q1 2015 | $244,000 | +916.7% | 7,916 | +1158.5% | 0.00% | – |
| Q4 2014 | $24,000 | +9.1% | 629 | +1.0% | 0.00% | – |
| Q3 2014 | $22,000 | -46.3% | 623 | -29.3% | 0.00% | – |
| Q2 2014 | $41,000 | – | 881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |